Figure 2.
Alprostadil prevent the incidence of contrast-induced nephropathy of coronary heart disease and diabetes in patients after coronary angiography.
Alprostadil prevent the incidence of contrast-induced nephropathy of coronary heart disease and diabetes in patients after coronary angiography.